BlackRock Health Company Profile: BME Business, Executives & Facts

Key StatisticsCurrency:USD

EPS(TTM)

1.68

P/E(TTM)

22.79

BVPS

39.17

P/B

0.98

Revenue(2024 FY)

7.57M

YoY

-7.65%

Net Income(2024 FY)

23.45M

YoY

17.17%

Gross Margin(TTM)

--

Net Margin(TTM)

309.96%

ROE(TTM)

4.14%

Debt ratio

0.77%

Dividend Yield(TTM)

7.74%

Payout Ratio

154.87%

Profile

Blackrock Health Sciences Trust

A Trust that primarily invested in stocks within the health sciences industry

Blackrock Health Sciences Trust was incorporated as a Delaware Statutory Trust on January 19, 2005 by agreement and declaration of trust, later amended and restated and governed by the laws of Delaware, and commenced operations on March 31, 2005. The fund is registered as a diversified, closed-end management investment company under the 1940 Act. The fund's investment objective is to provide total return through a combination of current income, current income and long-term capital appreciation. The Fund aims to achieve this by investing primarily in equity securities of companies engaged in health science and related industries, as well as equity derivatives with exposure to the health science industry.

Related Sections

C
Capital Markets+2.93%
A
Asset Management and Custody Banking+2.90%

Revenue BreakdownCurrency:USD

Data source:2024 FY

Total

7.57M

Name

Revenue

Proportion

Dividends-Unaffiliated

6.53M

86.29%

Dividends-Affiliated

1.06M

14.02%

Securities Lending Income-Affiliated-Net

3.63K

0.048%

Foreign Taxes Withheld

-27.57K

-0.36%

Major shareholders

No Data

DividendsCurrency:USD

Net Income Attributable to Parent

Total Cash Dividends

Payout Ratio

Declaration Date

Dividend Per Share

Ex-Div Date

Mar 3, 2025

Cash dividend: 0.26USD

Mar 14, 2025

Feb 3, 2025

Cash dividend: 0.26USD

Feb 14, 2025

Jan 2, 2025

Cash dividend: 0.26USD

Jan 15, 2025

Institutional Holdings

Totally

71

institutions reported their ownerships on

BME

Institutional Holding Ratio

Price

Insider Transactions

Net increase

Net decrease

Price

Executive Profile

Feedback

Disclaimer: All data and information presented above are from third-party data sources. They are for reference only and do not constitute any investment advice.

Market Data Risk Disclosure|Privacy Policy